Introducing the Atropos Evidence™ Agent–seamlessly integrating RWE into the clinical workflow.

Read the release
Learn more
Logo
  • Solutions
        • Health Systems
          • Pharmacy
          • Research Informatics
          • Value Based Care / Quality
          • GME
        • Life Sciences
          • Brand Analytics
          • Precision Medicine AI/ML
          • HEOR, Medical Affairs & RWE
          • Research & Development
          • Commercial Analytics
  • Technology
        • Platform
          • GENEVA OS®
        • Evidence Generation Tools
          • ChatRWD®
          • Green Button®
          • Alexandria®
          • Forge®
          • Atropos Evidence™ Agent
        • Data
          • Atropos Evidence™ Network
          • Data Quality Scoring
  • About
    • About Us
    • Careers
  • Resources
    • Resource Center
    • Publications
    • Customer Stories
    • News & Media
    • Press Releases
  • Contact Us
  • Login
Impact AI Podcast: Real-World Evidence for Healthcare with Dr. Brigham Hyde from Atropos Health

Impact AI Podcast: Real-World Evidence for Healthcare with Dr. Brigham Hyde from Atropos Health

by Joy Somogyi | Nov 18, 2024 | Blog, Podcast

In the latest episode of the Impact AI podcast, Dr. Brigham Hyde, CEO and co-founder of Atropos Health spoke with Heather D. Couture, Ph.D. about: Why AI is important for healthcare: the evidence gap. Atropos Health’s perspective on the role of real-world evidence....
Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy

Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy

by Joy Somogyi | Oct 25, 2024 | Blog, Publications

A new paper titled “Inflammatory vaginitis in women with multiple sclerosis: a retrospective analysis of B-cell depleting therapy compared to other disease modifying therapies” was published in Multiple Sclerosis and Related Disorders by authors Sarah...
ChatRWD™ Exceeds Expectations in Beta and now Available to Clinicians and Researchers

ChatRWD™ Exceeds Expectations in Beta and now Available to Clinicians and Researchers

by Joy Somogyi | Oct 22, 2024 | Press Release

Overwhelmingly Positive Performance and Results from Beta Users Accelerate Product Availability to Additional Users PALO ALTO, Calif. – October 22, 2024 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world...
Utilization of High-Sensitivity C-Reactive Protein Testing in Primary and Secondary ASCVD Prevention

Utilization of High-Sensitivity C-Reactive Protein Testing in Primary and Secondary ASCVD Prevention

by Joy Somogyi | Oct 18, 2024 | Publications

On October 18, 2024, at the 19th Annual Cardiometabolic Health Congress (CMHC), a poster titled “Utilization of High-Sensitivity C-Reactive Protein Testing in Primary and Secondary ASCVD Prevention” was presented by authors Emil deGoma, MD, Yung Chyung,...
Developing Publication-Grade Evidence for Healthcare and Life Sciences: Lessons from Neil Sanghavi, President and Head of Product and Solutions of Atropos Health

Developing Publication-Grade Evidence for Healthcare and Life Sciences: Lessons from Neil Sanghavi, President and Head of Product and Solutions of Atropos Health

by Joy Somogyi | Oct 8, 2024 | Blog, Podcast, White Paper

In the latest episode of the Pear Healthcare Playbook with Pear VC, Neil Sanghavi, President of Atropos Health spoke with Andrew Parambath about health tech, the role of data in healthcare, and Atropos Health’s innovative growth strategy, go-to-market approach, the...
« Older Entries
Next Entries »
DiviWP Logo
  • Follow
  • Follow

Solutions

Health Systems

Pharmacy

Research Informatics

Value Based Care / Quality

GME

Life Sciences

Brand Analytics

Precision Medicine AI/ML

HEOR, Medical Affairs & RWE

Research & Development

Commercial Analytics

Technology

Platform

GENEVA OS®

Evidence Generation Tools

ChatRWD®

Green Button®

Alexandria®

Forge®

Atropos Evidence™ Agent

Data

Atropos Evidence™ Network

Data Quality Scoring

About

  • About Us
  • Careers

Resources

  • Resources Center
  • Publications
  • Customer Stories
  • News & Media
  • Press Releases

Copyright © 2026 Atropos Health. All Rights Reserved | Privacy Policy | Ethics Report | Terms of Service

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}